)
The markets are likely to open on a flat note tracking mixed global cues. In addition, WPI and CPI numbers which are due to be released today will be keenly watched by the market participants.
Asian share markets edged higher on Monday as euro zone banking jitters faded, to be replaced by caution ahead of corporate earnings and a raft of global economic events including testimony from the head of the Federal Reserve.SGX Nifty is quoting at 7,478.50 lower by 0.04%
MSCI's broadest index of Asia-Pacific shares outside Japan .MIAPJ0000PUS was up 0.2 percent, with Seoul .KS11 putting on 0.4 percent. Japan's Nikkei .N225 rose a modest 0.2 percent after several sessions of losses.
European markets had calmed on Friday as investors decided that losses associated with the founding family of Banco Espirito Santo (BES.LS) were unlikely to disrupt Portugal's financial system or revive broader worries about the bloc's weaker economies.
Stocks to watch:
Tata Power, which is pursuing “aggressive growth plans”, has sought shareholders’ nod to raise up to Rs 7,000 crore through issue of non-convertible debentures (NCDs). Besides, the leading private power utility has proposed increasing its borrowing limit to Rs 27,000 crore.
Renewable energy generator Welspun Energy Pvt Ltd (WEPL) has started work for setting up of 50-MW solar project at Baramati Maharashtra. The company is setting up the project on a public-private partnership (PPP) model with Maharashtra State Power Generation Company, Welspun Energy said in a statement.
Tata group's flagship Jaguar Land Rover (JLR) is developing much smarter cars that will offer a completely personalised driving experience and help prevent accidents by reducing driver distraction.
Polaris Financial Technology is likely to remain in focus after Orbitech Limited sold 6,16,400 shares of Polaris at Rs 226.93.
Sun Pahrma is likely to remain in focus after Caraco Pharmaceutical Laboratories, a subsidiary of Sun Pharma , has decided to recall some lots of Venlafaxine Hydrochloride extended-release tablets from the US market. According to a notification by the FDA, the recall of 26,530 units of 30-count bottles and 14,597 units of 90-count bottles is voluntarily initiated by the company through a letter to the regulator last month under 'Class-II' classification.
